Effect of long-term bronchodilator therapy on pulmonary function tests and exercise tolerance in patients with stable chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Mechanisms of improved exercise tolerance in COPD in response to tiotropium Source: Eur Respir J 2002; 20: Suppl. 38, 288s Year: 2002
Pulmonary hypertension reduces exercise tolerance in COPD Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010
Effect of treatment on exercise endurance tolerance and ventilatory efficiency in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011
Effect of formoterol on exercise tolerance in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 214s Year: 2004
Effects of bronchodilators on dynamic hyperinflation. Implications for exercise tolerance Source: Annual Congress 2006 - Management of dynamic hyperinflation during exercise in COPD Year: 2006
A comparison about effects of different broncodilators on pulmonary function and exercise tolerance tests for patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 63s Year: 2006
Effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise Source: Eur Respir J 2001; 18: Suppl. 33, 324s Year: 2001
The effect of different bronchodilator drugs on pulmonary function tests, exercise capacity and quality of life in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 515s Year: 2005
Pulmonary hemodynamics during an intermittent exercise test in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 405s Year: 2003
ACE-inhibition improves peak exercise oxygen uptake and ventilation in COPD: an effect unrelated to pulmonary function Source: Eur Respir J 2003; 22: Suppl. 45, 205s Year: 2003
Impact of exercise modality on exercise tolerance and functional capacity in patients with COPD Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention Year: 2010
Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012
Respiratory muscle strength and exercise tolerance before and after pulmonary rehabilitation in COPD patients Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
Adaptation of the metabolic response to exercise following pulmonary rehabilitation in COPD Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008
Effect of pulmonary rehabilitation on cardiac output responses during exercise in COPD Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Effects of tiotropium and salmeterol/fluticasone combination on lung hyperinflation, dyspnea and exercise tolerance in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006
Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005
Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010
Pulmonary haemodynamics during exercise in COPD Source: International Congress 2015 – Clinical relevance of exercise stress testing of the right ventricle pulmonary circulation unit Year: 2015